Literature DB >> 18466115

The TSC1-TSC2 complex: a molecular switchboard controlling cell growth.

Jingxiang Huang1, Brendan D Manning.   

Abstract

TSC1 and TSC2 are the tumour-suppressor genes mutated in the tumour syndrome TSC (tuberous sclerosis complex). Their gene products form a complex that has become the focus of many signal transduction researchers. The TSC1-TSC2 (hamartin-tuberin) complex, through its GAP (GTPase-activating protein) activity towards the small G-protein Rheb (Ras homologue enriched in brain), is a critical negative regulator of mTORC1 (mammalian target of rapamycin complex 1). As mTORC1 activity controls anabolic processes to promote cell growth, it is exquisitely sensitive to alterations in cell growth conditions. Through numerous phosphorylation events, the TSC1-TSC2 complex has emerged as the sensor and integrator of these growth conditions, relaying signals from diverse cellular pathways to properly modulate mTORC1 activity. In the present review we focus on the molecular details of TSC1-TSC2 complex regulation and function as it relates to the control of Rheb and mTORC1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466115      PMCID: PMC2735030          DOI: 10.1042/BJ20080281

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  130 in total

1.  Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Pauline Bonner; Rosa Bernardi; David Neal Franz; David Witte; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling.

Authors:  Greg M Findlay; Lijun Yan; Julia Procter; Virginie Mieulet; Richard F Lamb
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

3.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

Authors:  Yasemin Sancak; Carson C Thoreen; Timothy R Peterson; Robert A Lindquist; Seong A Kang; Eric Spooner; Steven A Carr; David M Sabatini
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

4.  Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase.

Authors:  Ya-Chieh Hsu; Joshua J Chern; Yi Cai; Mingyao Liu; Kwang-Wook Choi
Journal:  Nature       Date:  2007-02-15       Impact factor: 49.962

5.  PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR.

Authors:  Hongbing Zhang; Natalia Bajraszewski; Erxi Wu; Hongwei Wang; Annie P Moseman; Sandra L Dabora; James D Griffin; David J Kwiatkowski
Journal:  J Clin Invest       Date:  2007-02-08       Impact factor: 14.808

Review 6.  Defining the role of mTOR in cancer.

Authors:  David A Guertin; David M Sabatini
Journal:  Cancer Cell       Date:  2007-07       Impact factor: 31.743

7.  IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway.

Authors:  Dung-Fang Lee; Hsu-Ping Kuo; Chun-Te Chen; Jung-Mao Hsu; Chao-Kai Chou; Yongkun Wei; Hui-Lung Sun; Long-Yuan Li; Bo Ping; Wei-Chien Huang; Xianghuo He; Jen-Yu Hung; Chien-Chen Lai; Qingqing Ding; Jen-Liang Su; Jer-Yen Yang; Aysegul A Sahin; Gabriel N Hortobagyi; Fuu-Jen Tsai; Chang-Hai Tsai; Mien-Chie Hung
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

8.  Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.

Authors:  F Jin; R Wienecke; G H Xiao; J C Maize; J E DeClue; R S Yeung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

Review 9.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain.

Authors:  R B Pearson; P B Dennis; J W Han; N A Williamson; S C Kozma; R E Wettenhall; G Thomas
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

View more
  527 in total

1.  Consequences of interrupted Rheb-to-AMPK feedback signaling in tuberous sclerosis complex and cancer.

Authors:  Markus D Lacher; Roxana J Pincheira; Ariel F Castro
Journal:  Small GTPases       Date:  2011-07-01

2.  PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.

Authors:  Ravi S Akundi; Lianteng Zhi; Hansruedi Büeler
Journal:  Neurobiol Dis       Date:  2011-09-16       Impact factor: 5.996

3.  mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells.

Authors:  Charles A Easley; Ahmi Ben-Yehudah; Carrie J Redinger; Stacie L Oliver; Sandra T Varum; Vonya M Eisinger; Diane L Carlisle; Peter J Donovan; Gerald P Schatten
Journal:  Cell Reprogram       Date:  2010-06       Impact factor: 1.987

4.  Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway.

Authors:  Makoto Taniguchi; Kazuyuki Kitatani; Tadakazu Kondo; Mayumi Hashimoto-Nishimura; Satoshi Asano; Akira Hayashi; Susumu Mitsutake; Yasuyuki Igarashi; Hisanori Umehara; Hiroyuki Takeya; Junzo Kigawa; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

5.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.

Authors:  Àlex Rovira; María Luz Ruiz-Falcó; Elena García-Esparza; Eduardo López-Laso; Alfons Macaya; Ignacio Málaga; Élida Vázquez; Josefina Vicente
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

6.  Phosphatidylinositol-5-Phosphate 4-Kinases Regulate Cellular Lipid Metabolism By Facilitating Autophagy.

Authors:  Mark R Lundquist; Marcus D Goncalves; Ryan M Loughran; Elite Possik; Tarika Vijayaraghavan; Annan Yang; Chantal Pauli; Archna Ravi; Akanksha Verma; Zhiwei Yang; Jared L Johnson; Jenny C Y Wong; Yilun Ma; Katie Seo-Kyoung Hwang; David Weinkove; Nullin Divecha; John M Asara; Olivier Elemento; Mark A Rubin; Alec C Kimmelman; Arnim Pause; Lewis C Cantley; Brooke M Emerling
Journal:  Mol Cell       Date:  2018-05-03       Impact factor: 17.970

7.  The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner.

Authors:  Minqing Jiang; Rohit Rao; Jincheng Wang; Jiajia Wang; Lingli Xu; Lai Man Wu; Jonah R Chan; Huimin Wang; Q Richard Lu
Journal:  Glia       Date:  2018-05-03       Impact factor: 7.452

8.  Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma.

Authors:  Darcy A Krueger; Marguerite M Care; Karen Agricola; Cindy Tudor; Maxwell Mays; David Neal Franz
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

Review 9.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

10.  Role of tumor suppressor TSC1 in regulating antigen-specific primary and memory CD8 T cell responses to bacterial infection.

Authors:  Sruti Krishna; Jialong Yang; Hongxia Wang; Yurong Qiu; Xiao-Ping Zhong
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.